Recent MSK Discoveries & Advances

Memorial Sloan Kettering researchers are relentlessly exploring every aspect of cancer — from basic investigations of cells and molecules to clinical trials of new treatments and population-wide studies of the disease. While our core mission is to translate this knowledge into new strategies to control cancer, many of our investigators are also making scientific progress against other diseases and conditions.

Below are some examples of discoveries and advances that recently were made in our laboratories and clinics, and featured in our news stories.

and/or
385 News Items found
Hematologic oncologist Martin Tallman and nurse practitioner Bernadette Cuello
Announcement
FDA Approves Ivosidenib (Tibsovo®), a Targeted Drug, for Acute Myeloid Leukemia

The drug provides a new treatment option for people whose cancer has stopped responding to other therapies.
This image shows cancer cells (white) and pericytes (green) clinging to capillaries (red). The blue dots are nuclei.
In the Lab
Scientists Identify Growth Signal for Metastatic Cancer "Seeds"

Targeting this signal with drugs might be one way to stop cancers from spreading.
CT scans of brains
Finding
Research Advances the Genetic Understanding of Pineoblastoma, a Rare Brain Cancer

The findings will lead to more accurate diagnoses and, potentially, to better treatments.
MSK computational biologist Barry Taylor
Finding
Double Jeopardy: Gene-Sequencing Test Uncovers New Clues about a Defect Seen in Many Tumors

MSK researchers have found that a genetic state in tumors called whole-genome doubling is connected with worse outcomes for people with cancer.
MSK physician-scientist Omar Abdel-Wahab
In the Lab
Splicing May Be an Effective Target in the Fight against Cancer

New drugs are being developed that target part of the process to make proteins.
Side-by-side images of brain MRIs.
Feature
New Imaging Technique Provides Snapshot of Brain Tumor Activity

A new imaging approach could shorten the time needed to determine whether a brain tumor treatment is working.
NK cells attacking
Feature
Meet the Unsung Immune Cell that Could Change Immunotherapy

A lesser-known immune cell is suddenly getting more attention in the field of cancer immunology.
Pink, blue, green, and white blob on black background
In the Clinic
Study Shows Liquid Biopsy Is Accurate for Guiding Prostate Cancer Treatment Choice

Detecting a protein in a blood sample could help doctors make treatment decisions for prostate cancer patients.
MSK computational biologist Dana Pe'er
In the Lab
One by One: Single-Cell Analysis Helps Map the Cancer Landscape

Sloan Kettering Institute investigators are taking important steps toward being able to identify all the cell types in tumors. With this information, they can figure out how the cells work together.
Leukemia cells
Finding
Findings from Two Patients Shed New Light on Drug Resistance in AML

A team at MSK has discovered a previously unknown type of resistance to a new leukemia drug.